375 related articles for article (PubMed ID: 19801517)
1. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
Carlsten M; Norell H; Bryceson YT; Poschke I; Schedvins K; Ljunggren HG; Kiessling R; Malmberg KJ
J Immunol; 2009 Oct; 183(8):4921-30. PubMed ID: 19801517
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
3. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ
J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292
[TBL] [Abstract][Full Text] [Related]
4. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.
Tahara S; Okumura G; Matsuo T; Shibuya A; Shibuya K
Int Immunol; 2024 Apr; 36(6):317-325. PubMed ID: 38289706
[TBL] [Abstract][Full Text] [Related]
5. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
Carlsten M; Björkström NK; Norell H; Bryceson Y; van Hall T; Baumann BC; Hanson M; Schedvins K; Kiessling R; Ljunggren HG; Malmberg KJ
Cancer Res; 2007 Feb; 67(3):1317-25. PubMed ID: 17283169
[TBL] [Abstract][Full Text] [Related]
6. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
7. Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.
Xiong P; Sang HW; Zhu M
Immunology; 2015 Nov; 146(3):369-78. PubMed ID: 26235210
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
9. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
Front Immunol; 2020; 11():40. PubMed ID: 32082316
[TBL] [Abstract][Full Text] [Related]
10. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell impairment in ovarian clear cell carcinoma.
Patrizi O; Rampinelli F; Coltrini D; Pesce S; Carlomagno S; Sivori S; Pascale A; Marcenaro E; Parolini S; Tabellini G
J Leukoc Biol; 2020 Oct; 108(4):1425-1434. PubMed ID: 32794325
[TBL] [Abstract][Full Text] [Related]
13. Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity.
Ott M; Avendaño-Guzmán E; Ullrich E; Dreyer C; Strauss J; Harden M; Schön M; Schön MP; Bernhardt G; Stadelmann C; Wegner C; Brück W; Nessler S
J Neuroinflammation; 2019 Feb; 16(1):49. PubMed ID: 30808363
[TBL] [Abstract][Full Text] [Related]
14. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
[TBL] [Abstract][Full Text] [Related]
15. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
Watzl C; Claus M
Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
Sandusky MM; Messmer B; Watzl C
Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
[TBL] [Abstract][Full Text] [Related]
18. DNAM-1 controls NK cell activation via an ITT-like motif.
Zhang Z; Wu N; Lu Y; Davidson D; Colonna M; Veillette A
J Exp Med; 2015 Nov; 212(12):2165-82. PubMed ID: 26552706
[TBL] [Abstract][Full Text] [Related]
19. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Gross CC; Schulte-Mecklenbeck A; Rünzi A; Kuhlmann T; Posevitz-Fejfár A; Schwab N; Schneider-Hohendorf T; Herich S; Held K; Konjević M; Hartwig M; Dornmair K; Hohlfeld R; Ziemssen T; Klotz L; Meuth SG; Wiendl H
Proc Natl Acad Sci U S A; 2016 May; 113(21):E2973-82. PubMed ID: 27162345
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.
Castriconi R; Dondero A; Corrias MV; Lanino E; Pende D; Moretta L; Bottino C; Moretta A
Cancer Res; 2004 Dec; 64(24):9180-4. PubMed ID: 15604290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]